Catalent reported 28.82 in PE Price to Earnings for its fiscal quarter ending in June of 2024.



Pe Change Date
Agilent 25.04 2.13 Dec/2025
AstraZeneca 27.29 5.8 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Bruker 81.36 60.11 Dec/2025
Centene 31.9 20.68 Dec/2025
Charles River Laboratories 43.58 0.86 Dec/2025
Cigna 10.56 0.76 Dec/2025
Danaher 39.67 4.06 Dec/2025
Dentsply International 29.99 15.81 Dec/2025
Elevance Health 13.38 0.67 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Glaxosmithkline 11.66 0.28 Dec/2025
Hologic 19.15 1.72 Dec/2025
Humana 26.05 7.23 Dec/2025
Illumina 30.38 15.53 Dec/2025
Intuitive Surgical 71.61 12.42 Dec/2025
IQVIA Holdings 26.59 2.03 Dec/2025
J&J 23.62 0.86 Dec/2025
Laboratory Of America 20.86 10.79 Dec/2025
Lonza 34.34 2.58 Dec/2025
McKesson 23.85 0.07 Dec/2025
Merck 20.56 7.18 Dec/2025
Merck 13.92 5.08 Dec/2025
Mettler Toledo International 32.41 2.38 Dec/2025
Novartis 17.85 2.11 Dec/2025
Pfizer 14.48 5.18 Dec/2025
Quest Diagnostics 19.77 2.4 Dec/2025
Repligen 164.06 23.88 Dec/2025
Revvity 49.87 16.58 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Supernus Pharmaceuticals 110.38 71.27 Dec/2025
Thermo Fisher Scientific 31 6.22 Dec/2025
UnitedHealth 19.79 1.71 Dec/2025
Veradigm 11.15 4.63 Sep/2022
Waters 35.29 8.46 Dec/2025
West Pharmaceutical Services 37.75 0.22 Dec/2025